Baltimore, MD
Stem Cell Therapy clinics in Baltimore
Stem-cell menus in Baltimore sit between Harbor East cash-pay suites and Charles Village / Midtown rooms that share referral gravity with Johns Hopkins and University of Maryland Medical campuses. Those hospital names are institutional brands, not private-clinic substitutes. The same "stem cell" label can mean same-day bone marrow or adipose product, an allogeneic cord pitch, or an investigational protocol. Those are not interchangeable.
This hub lists Directory clinics for Baltimore and stem-cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend. We omit invented city price averages.
Ask cell or tissue source, same-day autologous versus allogeneic, who performs the procedure, how adverse events are handled, and whether marketing matches FDA product category (Section 361 versus IND or BLA pathways). Inner Harbor tourism copy does not clean up private-clinic claims. Prefer plain-language risk talk. Use the national stem-cell Directory and Guide, then return here for Baltimore listings.
3 Clinics
MD on staff
Whole Body Healthcare
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
- Migraine Treatment
Regulatory context
A note on Maryland's stem cell therapy rules.
Maryland cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Maryland for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Maryland is FDA's home state, and the agency operates extensive review and inspection capacity within state lines.
-
Maryland Medical Practice Act, Health Occupations Article Title 14
Establishes physician licensure and discipline through the Maryland Board of Physicians. -
Maryland Pharmacy Act, Health Occupations Article Title 12
Regulates compounding pharmacies aligned with federal 503A and 503B standards. -
Maryland Consumer Protection Act, Commercial Law Article Title 13
Empowers the Attorney General to pursue deceptive marketing claims against providers making unsupported clinical claims.
Maryland's proximity to FDA headquarters in Silver Spring places state clinics under close federal observation. The FDA has corresponded with Maryland providers offering cellular therapies. The Maryland Board of Physicians has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Maryland Attorney General's Consumer Protection Division can pursue deceptive marketing under the Maryland Consumer Protection Act. NIH and academic medical centers in the Baltimore-DC corridor conduct compliant IND-based cellular research, which contrasts with smaller direct-to-patient clinics that may be operating without appropriate authorization.
Stem Cell Therapy in Baltimore, answered.
Available here
Other Treatments available in Baltimore
- Arthritis Treatment in Baltimore
- Chelation Therapy in Baltimore
- Erectile Dysfunction (ED) Treatment in Baltimore
- Hormone Replacement Therapy (HRT) in Baltimore
- IV Hydration in Baltimore
- IV Therapy in Baltimore
- Ketamine Therapy in Baltimore
- Migraine Treatment in Baltimore
- NAD IV Therapy in Baltimore
- Ozone Therapy in Baltimore
- Peptide Therapy in Baltimore
- PRP Therapy in Baltimore
- Psychedelic Therapy in Baltimore
- Red Light Therapy in Baltimore
- Testosterone Replacement Therapy (TRT) in Baltimore
- TMJ Treatment in Baltimore
- Vitamin IV Therapy in Baltimore
Nationwide
Stem Cell Therapy clinics across the US